Skoči na glavni sadržaj

Ostalo

https://doi.org/10.15836/ccar2022.155

Clinical outcomes of atrial fibrillation and acute myocardial infarction in long-term follow up

Petra Bistrović orcid id orcid.org/0000-0002-3650-3297 ; Dubrava University Hospital, Zagreb, Croatia
Ivan Skorić orcid id orcid.org/0000-0002-5201-2092 ; University of Zagreb, School of Medicine, Zagreb, Croatia
Irzal Hadžibegović orcid id orcid.org/0000-0002-3768-9134 ; Dubrava University Hospital, Zagreb, Croatia
Tomislav Šipić orcid id orcid.org/0000-0001-8652-4523 ; Dubrava University Hospital, Zagreb, Croatia
Šime Manola orcid id orcid.org/0000-0001-6444-2674 ; Dubrava University Hospital, Zagreb, Croatia
Ivana Jurin orcid id orcid.org/0000-0002-2637-9691 ; Dubrava University Hospital, Zagreb, Croatia


Puni tekst: engleski pdf 130 Kb

str. 155-155

preuzimanja: 128

citiraj

Preuzmi JATS datoteku


Sažetak

Ključne riječi

atrial fibrillation; myocardial infarction; acute coronary syndrome

Hrčak ID:

286734

URI

https://hrcak.srce.hr/286734

Datum izdavanja:

8.12.2022.

Posjeta: 446 *



Introduction: Atrial fibrillation (AF) and acute myocardial infarction (MI) often coexist together, whether it is MI in patients with earlier AF or AF as a complication of MI. Previously published work has shown results indicating worse quality of life in patients with both AF and MI, with some potential differences in long-term outcomes depending on time of fibrillation onset. (1,2) We aimed to compare clinical outcomes of IM patients with prior and new onset AF at two tertiary centers.

Patients and Methods: We evaluated 1662 patients discharged after acute MI at Dubrava University Hospital and „Merkur“ University Hospital from January 2017 to December 2021, followed up to present date. Among them, 28 patients who were discharged had AF prior to MI, whereas 42 patients had newly diagnosed AF. We compared the differences in baseline characteristics, all cause death as the primary outcome and all-combined MACE events as secondary outcome in follow up between patients without AF, prior AF and new onset AF.

Results: Our results show that patients with AF diagnosed after MI were significantly older and were discharged with lower eGFR and left ventricular ejection fraction compared to the other groups (p<0.05). After comparing the groups in follow up, the new onset AF group had significantly lower survival time (HR 3.24 compared to no AF, HR 4.71 compared to prior AF, p<0.001). However, in multivariate analysis after adjustment for clinically relevant parameters, there was no significant difference in survival probability between the groups. There was no statistically significant difference in free-from MACE time between the three groups.

Conclusion: Our data suggests potentially increased long-term mortality in those who develop AF in the acute setting of MI. Further research is necessary to evaluate the potential risks of new onset AF and to develop strategies for its prevention.

LITERATURE

1 

Carnicelli AP, Owen R, Pocock SJ, Brieger DB, Yasuda S, Nicolau JC, et al. Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction. Open Heart. 2021 December;8(2):e001726. https://doi.org/10.1136/openhrt-2021-001726 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/34911791

2 

Tseng CH, Chung WJ, Li CY, Tsai TH, Lee CH, Hsueh SK, et al. Statins reduce new-onset atrial fibrillation after acute myocardial infarction: A nationwide study. Medicine (Baltimore). 2020 January;99(2):e18517. https://doi.org/10.1097/MD.0000000000018517 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/31914024


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.